FDA Adverse Event Injury Summary report: N

INTERGARD KNITTED

MDR report key: 8304062 · Received February 5, 2019

Report

Report Number
1640201-2019-00006
Event Type
Injury
Date Received
February 5, 2019
Date of Event
December 30, 2018
Report Date
June 26, 2019
Manufacturer
INTERVASCULAR SAS
Product Code
DSY
UDI-DI
00384401000471
PMA / PMN Number
K964625
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THE RETURNED GRAFT WAS ANALYZED BY AN EXTERNAL AND INDEPENDENT LABORATORY. THE MACROSCOPIC ANALYSIS SHOWED NO TEXTILE ABNORMALITY SUCH AS TEARS, LOSS OF TEXTILE COHESION, HOLES OR SIGNS OF CUT. SPECIFICALLY, NO SIGNIFICANT TEXTILE CHANGES WAS EVIDENCED AT THE BIFURCATION AREA. AT THE BASIS OF SUTURE LINE, ACCUMULATION OF BLOOD MATERIAL COULD BE DETECTED. THE SCANNING ELECTRON MICROSCOPY (SEM) ANALYSIS OF TWO SELECTED SEGMENTS (ONE OF EACH LEG OF THE BIFURCATED GRAFT) SHOWED MASSIVE BLOOD MATERIAL INFILTRATION THAT HINDERED APPRAISAL OF THE COLLAGEN MATERIAL. THE INVESTIGATION IS STILL ONGOING. A FOLLOW-UP REPORT WILL BE SENT UPON COMPLETION OF THE INVESTIGATION.

Additional Manufacturer Narrative · 0

(4315) THE CASE HAS BEEN ENTIRELY REVIEWED BY OUR CORPORATE MEDICAL OFFICER, WHO STATES THAT, "CONSIDERING ALL THE INFORMATION [...], IT IS NOT POSSIBLE TO MAKE ANY FURTHER STATEMENT REGARDING THE CAUSE OF THE BLEEDING". THE CAUSE OF THE EVENT REMAINS UNKNOWN. HOWEVER, THE CONDUCTED INVESTIGATION SUGGESTS THAT THE DEVICE WAS NOT DEFECTIVE AT THE TIME OF MANUFACTURING.

Additional Manufacturer Narrative · 1

THE INVOLVED DEVICE WAS SENT TO AN EXTERNAL AND INDEPENDENT LABORATORY FOR EXAMINATION. THE INVESTIGATION IS ONGOING. A REVIEW OF THE COMPLAINT DEVICE HISTORY RECORDS, INDICATED THAT THE GRAFT WAS PROCESSED AND INSPECTED ACCORDING TO ESTABLISHED PROCEDURES AND WAS THEREFORE RELEASED FOLLOWING ACCEPTABLE QUALITY INSPECTIONS AND TESTS. SPECIFICALLY, NO ANOMALY WAS EVIDENCED IN THE COLLAGEN COATING RECORDS. MOREOVER, THE REVIEW OF THE WATER PERMEABILITY TESTING RECORDS OF PRODUCTS COATED ON THE SAME PERIOD/DAY AS THE COMPLAINT DEVICE INDICATED VALUES WELL WITHIN PRODUCT SPECIFICATIONS (< 5 ML/CM²/MIN). ONE RETENTION SAMPLE COATED ON THE SAME DAY AND UNDER THE SAME CONDITIONS AS THE INVOLVED DEVICE UNDERWENT WATER PERMEABILITY TESTING. THE TEST RESULT INDICATED A VALUE WELL WITHIN PRODUCT SPECIFICATIONS (< 5 ML/CM²/MIN). THE REVIEW OF POST-MARKETING HISTORICAL DATA INDICATED THAT NO OTHER SIMILAR COMPLAINT WAS REPORTED FOR THE SAME LOT NUMBER. A VIDEO OF THE SURGERY WAS PROVIDED BY THE USER, SHOWING EVIDENCE OF THE BLOOD LEAKAGE. THE CORPORATE MEDICAL OFFICER CAREFULLY OBSERVED THIS VIDEO AND COMMENTED THAT "BECAUSE OF THE TWO BRANCHES ARE CLAMPED TOGETHER AND AT 90 DEGREES ANGLE FROM THE PROXIMAL ANASTOMOSIS, IT IS DIFFICULT TO ACCURATELY DISCRIMINATE WHERE THE BLEEDING IS COMING FROM. IT DOES APPEAR THAT IT IS COMING MOSTLY FROM AN AREA AT THE GRAFT BIFURCATION AND TO BE A CONTINUOUS STREAM WITH PULSATILE FLOW CHARACTERISTICS (NOT DIFFUSED)." THE COMMENTS FROM R&D ARE THE FOLLOWING: "AT A FIRST GLANCE, IT LOOKS LIKE THE BLEEDING WAS MOSTLY ORIGINATING FROM THE CROTCH, HOWEVER, LOOKING AT A LOWER SPEED, IT SEEMS THAT BLEEDING FIRST OCCURRED ON THE LEGS BEFORE AFFECTING THE CROTCH ." THE INVESTIGATION IS STILL ONGOING. A FOLLOW-UP REPORT WILL BE SENT UPON COMPLETION OF THE INVESTIGATION.

Description of Event or Problem · 1

AFTER THE BIFURCATED GRAFT WAS PLACED IN THE PATIENT, BLOOD OOZED FROM ALL OVER THE GRAFT. THE AMOUNT OF BLOOD LEAKAGE IS UNKNOWN. THE SURGEON REPLACED IT WITH ANOTHER GRAFT WITH REFERENCE IGK1608 (I.E. ONE WITH A LARGER DIAMETER) AND NO BLOOD LEAKAGE OCCURRED WITH THIS SECOND GRAFT. THE SURGERY WAS PROLONGED FOR 15-20 MINUTES. THE GRAFT IS AVAILABLE FOR INVESTIGATION. A VIDEO OF THE BLEEDING IS AVAILABLE FOR INVESTIGATION. THE PATIENT'S CONDITION IS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
97927 INTERGARD KNITTED VASCULAR POLYESTER GRAFT DSY INTERVASCULAR SAS IGK1407 17C02 00384401000471

Patients

Seq Age Sex Outcome Treatment
1 80 YR Required Intervention